Cite
Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis--results from the IDEA study.
MLA
Bissell, Lesley-Anne, et al. “Improvement in Insulin Resistance Is Greater When Infliximab Is Added to Methotrexate during Intensive Treatment of Early Rheumatoid Arthritis--Results from the IDEA Study.” Rheumatology, vol. 55, no. 12, Dec. 2016, pp. 2181–90. EBSCOhost, https://doi.org/10.1093/rheumatology/kew306.
APA
Bissell, L.-A., Hensor, E. M. A., Kozera, L., Mackie, S. L., Burska, A. N., Nam, J. L., Keen, H., Villeneuve, E., Donica, H., Buch, M. H., Conaghan, P. G., Andrews, J., Emery, P., & Morgan, A. W. (2016). Improvement in insulin resistance is greater when infliximab is added to methotrexate during intensive treatment of early rheumatoid arthritis--results from the IDEA study. Rheumatology, 55(12), 2181–2190. https://doi.org/10.1093/rheumatology/kew306
Chicago
Bissell, Lesley-Anne, Elizabeth M. A. Hensor, Lukasz Kozera, Sarah L. Mackie, Agata N. Burska, Jacqueline L. Nam, Helen Keen, et al. 2016. “Improvement in Insulin Resistance Is Greater When Infliximab Is Added to Methotrexate during Intensive Treatment of Early Rheumatoid Arthritis--Results from the IDEA Study.” Rheumatology 55 (12): 2181–90. doi:10.1093/rheumatology/kew306.